Does A One-Site CDMO Make A Difference In Drug Development?

Drug development is increasingly complex due to evolving scientific understanding, new technologies, and shifts in regulatory and geopolitical landscapes. As a result, choosing the right CDMO is crucial, as they serve as a strategic extension of a biotech company.

One important factor in this choice is the CDMO's physical structure. A one-site CDMO houses GMP, R&D, and manufacturing operations all under one roof. This integrated model provides substantial benefits, especially for small to medium-sized biotechs. It streamlines logistics and communication, allowing for faster decision-making and eliminating delays from cross-site coordination. For example, tech transfer becomes smoother and faster because teams can collaborate in real time without needing to ship materials or documents between locations. This helps compress timelines and accelerates the path to clinic or market.

Discover how a single-site approach can enhance your project's efficiency, quality oversight, and scalability.